GL Pharm Tech Corp. Logo

GL Pharm Tech Corp.

Develops incrementally modified drugs using advanced drug delivery technologies.

204840 | KO

Overview

Corporate Details

ISIN(s):
KR7204840003
LEI:
Country:
South Korea
Address:
경기도 성남시 수정구 달래내로 46 성남글로벌융합센터 210호, 성남시

Description

GL Pharm Tech Corp. is a pharmaceutical company specializing in the development of incrementally modified drugs (IMDs). The company focuses on creating improved versions of existing pharmaceutical products by utilizing advanced drug formulation and delivery technologies. Its core mission is to enhance the therapeutic value and safety of marketed drugs, with a specific emphasis on reducing side effects and improving patient convenience. GL Pharm Tech is actively engaged in research and development, managing a pipeline of drug candidates and conducting clinical trials to support the commercialization of its enhanced pharmaceutical products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-03-06 00:00
최대주주변경
Korean 30.5 KB
2024-03-06 00:00
기타시장안내(최대주주의의무보유관련)
Korean 5.0 KB
2024-03-05 00:00
주식등의대량보유상황보고서(일반)
Korean 82.5 KB
2024-02-28 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 30.6 KB
2024-02-28 00:00
[기재정정]최대주주변경을수반하는주식양수도계약체결
Korean 34.1 KB
2024-02-28 00:00
임시주주총회결과
Korean 12.9 KB
2024-02-28 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 8.7 KB
2024-02-14 00:00
의결권대리행사권유참고서류
Korean 42.8 KB
2024-02-13 00:00
[기재정정]주주총회소집결의
Korean 19.7 KB
2024-02-13 00:00
주주총회소집공고
Korean 54.1 KB
2024-01-31 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 12.0 KB
2024-01-16 00:00
주주총회소집결의(임시주주총회)
Korean 6.8 KB
2024-01-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.0 KB
2023-12-15 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.0 KB
2023-12-05 00:00
주식등의대량보유상황보고서(일반)
Korean 78.3 KB

Automate Your Workflow. Get a real-time feed of all GL Pharm Tech Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GL Pharm Tech Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GL Pharm Tech Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cessatech A/S Logo
A biotech company developing medicines for children's acute pain management.
Denmark
CESSA
CG Invites Co., Ltd. Logo
A biopharmaceutical company specializing in digital genomics and personalized medicine.
South Korea
083790
CG Oncology, Inc. Logo
Develops bladder-sparing oncolytic immunotherapies for urologic cancers.
United States of America
CGON
CHA Vaccine Research Institute Logo
Develops vaccines and immunotherapeutics using proprietary adjuvant platforms.
South Korea
261780
Develops and manufactures veterinary medicines and functional feed additives.
South Korea
052670
Chemical Works of Gedeon Richter Plc Logo
Vertically integrated pharma company focused on women's health and other therapies.
Hungary
RICHT
Chemomab Therapeutics Ltd. Logo
Clinical-stage biotech developing therapeutics for fibro-inflammatory diseases.
United States of America
CMMB
CHINA PHARMA HOLDINGS, INC. Logo
Develops, manufactures, and markets prescription, OTC, and nutritional products.
United States of America
CPHI
China SXT Pharmaceuticals, Inc. Logo
Researches, develops, manufactures, and sells traditional Chinese medicine products.
United States of America
SXTC
ChoA Pharmaceutical Co., LTD. Logo
Develops, manufactures, and sells pharmaceutical products and health supplements.
South Korea
034940

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.